Sarepta Therapeutics' (SRPT) Outperform Rating Reiterated at Oppenheimer Holdings Inc

Sergio Conner
January 14, 2018

Advantus Capital Management Inc who had been investing in Highwoods Properties Inc for a number of months, seems to be bullish on the $5.06 billion market cap company.

Sarepta Therapeutics (NASDAQ:SRPT) traded up $2.53 during midday trading on Friday, reaching $61.52.

Curis, Inc. (NASDAQ:CRIS) shares ended at $0.7 with 1.56 mln shares exchanging hands. It has outperformed by 1.89% the S&P500.

Jason Karp increased its stake in Sarepta Therapeutics Inc (Put) (SRPT) by 170.07% based on its latest 2017Q3 regulatory filing with the SEC.

Sarepta Therapeutics, Inc. (SRPT) opened the session with a $59.16 price tag, later ranging from $57.661 to $60.22, the range at which the stock has traded at throughout the day. The institutional investor held 150,000 shares of the health care company at the end of 2017Q3, valued at $6.80M, down from 383,047 at the end of the previous reported quarter. The stock increased 1.61% or $1.1279 during the last trading session, reaching $71.0079. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) has risen 96.82% since January 12, 2017 and is uptrending. It has outperformed by 80.12% the S&P500.The move comes after 7 months positive chart setup for the $3.97B company. One research analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company's stock. Therefore 94% are positive. Analysts have placed a $69.78 price target on Sarepta Therapeutics, Inc., suggesting a 18.29% gain from recent close. Finally, Oppenheimer reaffirmed a buy rating and issued a $76.00 target price on shares of Sarepta Therapeutics in a research report on Monday, October 16th. The firm earned "Buy" rating on Wednesday, September 9 by SunTrust. As per Friday, July 21, the company rating was maintained by William Blair. The firm has "Neutral" rating by SunTrust given on Tuesday, September 1. Jefferies maintained the stock with "Buy" rating in Wednesday, June 14 report. Robert W. Baird maintained it with "Outperform" rating and $102 target in Monday, September 19 report. The firm has "Neutral" rating by Susquehanna given on Monday, October 26.

Since August 3, 2017, it had 0 buys, and 9 sales for $16.47 million activity. (NASDAQ:SRPT). Natl Asset Mgmt Incorporated reported 8,089 shares.

Ant McPartlin Has Filed For Divorce From Wife Lisa Armstrong
Ant, 42, who has battled a prescription drugs addiction will split from his wife "to do the right thing for his health". Still, Lisa took to Twitter as recently as November to deny that she and her husband were "estranged".

The 4 Talking Points From Bournemouth 2-1 Arsenal
There was a surprise omission from the the Gunners squad as Sanchez was left out amid reports of a move to Manchester United . Mesut Ozil was also missing because of injury and Arsenal's lineup looked a shadow of the past teams under Wenger.

Vikings activate Bradford from IR for playoff game
At least there's no argument about Keenum being Minnesota's starter anymore, right? Minnesota waived tight end Kyle Carter to make room on the roster for Bradford.

Investors sentiment decreased to 1.4 in Q3 2017. Its up 0.09, from 1.03 in 2017Q2.

A number of large investors have recently modified their holdings of SRPT. Jennison Associates LLC raised its stake in Sarepta Therapeutics by 103.9% in the third quarter. 44,863 were reported by Manufacturers Life Ins The. LLC lifted its position in shares of Sarepta Therapeutics by 3,599.4% in the 3rd quarter. Jpmorgan Chase & reported 0% in Sarepta Therapeutics, Inc. Commonwealth Of Pennsylvania Public School Empls Retrmt has 0.01% invested in The J.M. Smucker Company (NYSE:SJM) for 9,237 shares. Lingnau Lutz also sold $109,850 worth of Nektar Therapeutics (NASDAQ:NKTR) shares. National Planning owns 0.05% invested in Sarepta Therapeutics, Inc. (NASDAQ:SRPT). Nationwide Fund holds 32,906 shares. Voya Investment Management LLC boosted its holdings in Sarepta Therapeutics by 2,786.1% during the second quarter. Oppenheimer analyst H. Singh now anticipates that the biotechnology company will post earnings of ($0.26) per share for the quarter, down from their prior estimate of ($0.21). Fred's, Inc. (NASDAQ:FRED), at its latest closing price of $4.09, it has a price-to-book ratio of 0.68, compared to an industry average at 5.28. Botty Investors Limited Co, Illinois-based fund reported 2,000 shares.

Among 15 analysts covering 3M (NYSE:MMM), 7 have Buy rating, 3 Sell and 5 Hold. Therefore 100% are positive. The stock of 3M Company (NYSE:MMM) earned "Equal-Weight" rating by Barclays Capital on Monday, October 5. As per Thursday, October 12, the company rating was maintained by Jefferies. RBC Capital Markets maintained 3M Company (NYSE:MMM) rating on Friday, July 24. That puts the market capitalization at $115.57 mln. Credit Suisse initiated the shares of SRPT in report on Tuesday, October 18 with "Outperform" rating. (NASDAQ:AMZN) earned "Outperform" rating by Credit Suisse on Friday, October 23. Motley Fool Wealth Management Llc bought 7,090 shares as the company's stock declined 7.64% while stock markets rallied. As per Wednesday, January 25, the company rating was maintained by Stifel Nicolaus. The stock of Avery Dennison Corporation (NYSE:AVY) earned "Hold" rating by Loop Capital on Thursday, October 26.

Advantus Capital Management Inc, which manages about $27.77B and $3.85B US Long portfolio, decreased its stake in Uniti Group Inc by 56,283 shares to 130,351 shares, valued at $1.91 million in 2017Q3, according to the filing. It also increased its holding in Luxoft Hldg Inc (NYSE:LXFT) by 343,270 shares in the quarter, for a total of 1.13 million shares, and has risen its stake in Constellation Brds (NYSE:STZ).

Investors sentiment increased to 1.12 in 2017 Q3. Its down 0.14, from 0.91 in 2017Q2. Royal Financial Bank Of Canada invested in 85,949 shares. 51 funds opened positions while 159 raised stakes. 148.76 million shares or 1.09% more from 147.16 million shares in 2017Q2 were reported. 80,202 are owned by Charter Com. London Of Virginia has invested 0% in 3M Company (NYSE:MMM). Tourbillon Partners Limited Partnership holds 1.68% or 1.53 million shares in its portfolio. Pnc Financial Service Gru has 162,921 shares for 0.01% of their portfolio. Cibc Mkts has invested 0.68% in 3M Company (NYSE:MMM). Switzerland-based Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% in Sarepta Therapeutics, Inc. Northern Trust Corporation reported 710,642 shares. State Of Alaska Department Of Revenue holds 30,985 shares. Parkside Commercial Bank reported 0% stake. Hemenway Ltd Liability Corporation accumulated 70,896 shares. 23,212 are held by Biondo Invest Advisors Limited Liability Company. Moreover, Jane Street Group Ltd has 0.92% invested in, Inc. Rock Springs Mgmt Limited Partnership holds 0.54% or 259,200 shares in its portfolio. The stock was sold at an average price of $55.89, for a total transaction of $372,618.63. Shares for $57,110 were sold by Hora Maninder. (NYSE:MSI) rating on Thursday, February 25. 6,998 shares were sold by CONRADO EDUARDO F, worth $623,707 on Tuesday, August 8. Equities analysts expect that Sarepta Therapeutics will post ($4.83) earnings per share for the current year. During the same quarter past year, the firm earned ($1.25) EPS. SJM's profit will be $243.09M for 14.42 P/E if the $2.14 EPS becomes a reality.

Other reports by

Discuss This Article